Literature DB >> 33275201

Regulation of mTOR by miR-107 to facilitate glioma cell apoptosis and to enhance cisplatin sensitivity.

P-F Su1, S-Q Song.   

Abstract

Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Regulation of mTOR by miR-107 to facilitate glioma cell apoptosis and to enhance cisplatin sensitivity, by P.-F. Su, S.-Q. Song, published in Eur Rev Med Pharmacol Sci 2018; 22 (20): 6864-6872-DOI: 10.26355/eurrev_201810_16155-PMID: 30402851" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/16155.

Entities:  

Year:  2020        PMID: 33275201     DOI: 10.26355/eurrev_202011_23745

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

Review 1.  NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review).

Authors:  Zhaomu Zeng; Yueyue Chen; Xiuchao Geng; Yuhao Zhang; Xichao Wen; Qingyu Yan; Tingting Wang; Chen Ling; Yan Xu; Junchao Duan; Kebin Zheng; Zhiwei Sun
Journal:  Int J Oncol       Date:  2022-05-04       Impact factor: 5.884

2.  Knockdown of DNA polymerase ζ relieved the chemoresistance of glioma via inhibiting the PI3K/AKT signaling pathway.

Authors:  Junbao Yang; Weilong Ding; Xiangyu Wang; Yongsheng Xiang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.